ACE Inhibitors, AngII Receptor Antagonists, Renin Inhibitors Flashcards

1
Q

What are the main antagonists used to treat hypertension?

A
  • Agents affecting RAAS
  • Thiazide diuretics
  • Calcium channel antagonists
  • β-adrenoceptor antagonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are ACEIs (‘prils’) also used to manage?

A
  • Cardiac failure
  • Following MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can ANGII Antagonists also be used to manage?

A
  • Cardiac failure (when ACEI contraindicated)
  • Diabetic nephropathy in Type II Diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe what stimulates renin release.

A
  • Baroreceptor responses to reduced renal arterial pressure and sympathetic stimulation of β1-adrenoceptors (by renal sympathetic nerves)
  • Reduced sodium intake and increased sodium loss
  • Decrease in renal tubular fluid Na+ concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the effects of Angiotensin II and what mediates its effects.

A
  • Vasoconstriction of efferent arterioles of glomerulus - increased glomerular filtration
  • Aldosterone secretion - increased renal sodium reabsorption/increased blood volume
  • Mediated by stimulation of angiotensin II type 1 (AT1) receptors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 ways AngII causes hypertension via the AT1 receptor?

(b) What would be the effects for AT2 receptor stimulation?

A
  • Vasoconstriction of afferent arterioles
  • Reduction in NO synthesis
  • Stimulation of aldosterone release from zona glomerulosa

(OPPOSITE TO THAT OF AT1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does AngII cause cardiac muscle hypertrophy through the AT1 receptor?

A
  • Release of IP3 - causes calcium release - increased inotropy and stroke volume
  • Results in normal remodelling of cardiac muscle to meet physiological demands
  • Can also occur due to failing to meet O2 demands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the mechanism of action and effects of ACEIs and aliskiren?

A
  • ACEIs - Competitive antagonism of ACE - inhibits conversion of ANGI to ANGII.
  • ALISKIREN - Competitive antagonism of renin. Inhibits conversion of Angiotensinogen to ANGI

BOTH:
- Dampens AT1 receptor activation (because reduced ANGII production)
- Reduced vascular tone
- Decreased aldosterone release and sodium reabsorption
- Increased bradykinin production - vasodilation by NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the mechanism of action and effects of AngII receptor antagonists.

A
  • Competitive antagonism of AT1 receptor - prevent ANGII binding
  • AT1 receptors in vasculature, adrenals and neuronal tissue are blocked
  • Decreases sympathetic activity
  • Reduced vascular resistance
  • Decreased aldosterone release (and thus sodium reabsorption)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the side effects and contraindications of renin inhibitors i.e aliskiren?

A
  • SIDE EFFECTS - Diarrhoea (especially at high doses), cough (less frequent than with ACEIs), angioedema, metabolised by CYP344 - subject to multiple drug interactions
  • CONTRAINDICATIONS - Pregnancy and don’t combine with ACEI/ANGII antagonists when treating HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the side effects and contraindications of ACEIs?

A
  • SIDE EFFECTS: Dry cough, hyperkalaemia, skin rash, hypotension and altered taste
  • CONTRAINDICATIONS - Pregnancy, renal artery stenosis (may progress to renal failure), other renal diseases(may cause reduction in renal function - used cautiously with constant renal function monitoring)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the side effects and contraindications of ANGII receptor antagonists?

When should it be used cautiously?

A
  • SIDE EFFECTS: Rare but serious allergic reactions, hypotension, hyperkalaemia
  • CONTRAINDICATIONS - Same as ACEIs but also contraindicated in severe hepatic impairment
  • USED CAUTIOUSLY when breastfeeding, mild to moderate hepatic impairment, elderly with persistent hypotension and/or hyperkalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the pharmacokinetics of ACEIs.

A
  • ADMINISTRATION - usually oral apart from enalaprilat (active metabolite of enalapril - available IV)
  • Many administered as prodrug - active forms polar, poor absorption in gut
  • ABSORPTION - varies from 55-75% (good and rapid) as either a prodrug or drug (captopril and lisinopril)
  • METABOLISM - All require hepatic metabolism bar captopril/lisinopril. t1/2: range from 1-5 hrs ramiprilat to 30-35 hrs enalaprilat
  • EXCRETION - Primarily by kidneys except FOSINOPRIL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the pharmacokinetics of ANGII Receptor antagonists.
Use the following examples:
- Candesartan (prodrug)
- Losartan (parent drug)
- Valsartan (parent drug

A
  • Administered orally.
  • C and L partially metabolised in liver to active metabolites
  • Usually renal excretion except valsartan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe what can cause heart failure.

A
  • Structural and functional cardiac disorders
15
Q

What element of heart failure can hypertension contribute to?

A
  • Increased wall stress leading to ventricular hypertrophy
16
Q

How does ventricular hypertrophy lead to diastolic ventricular dysfunction?

A

Impaired diastolic filling due to:
- Impaired myocardial relaxation
- Increased stiffness in the ventricular wall
- Decreased left ventricular compliance
O2 DEMANDS OF TISSUES CANNOT BE MET BY HEART

17
Q

Describe how ACE inhibitors work in heart failure.

A
  • Cause decreased ANGII production resulting in a vasodilation and decreased TPR
  • Decreases further ventricular hypertrophy
  • Cardiac output becomes sufficient for perfusion
17
Q
A